• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PROF

PROF

Profound Medical Corp.

NASDAQHealthcareMedical - DevicesCA

USD6.55

+0.07 (+1.08%)

Rating:C-

Company Profile

CEO

Arun Swarup Menawat

IPO Date

2019-10-29

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

CA

Market Metrics

Open

$6.50

Prev. Close

$6.48

Day Low

$6.47

Day High

$6.61

52W Low

$3.76

52W High

$8.95

Market Cap

$0.20B

Volume

0.04M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

5.6%

Avg Negative

2.4%

Avg Neutral

91.8%

News Feed

Profound Medical to Participate in A.G.P.'s Virtual MedTech Summer Conference

GlobeNewsWire·7/22/2021·↑ positive

Profound Medical to Release Second Quarter 2021 Financial Results on August 4 – Conference Call to Follow

GlobeNewsWire·7/15/2021·↑ positive

Profound Medical to Participate in June Investor Conferences

GlobeNewsWire
·5/25/2021
·↑ positive

Profound Medical Announces Voting Results from the 2021 Annual Meeting of Shareholders and Management Changes

GlobeNewsWire·5/19/2021·↑ positive

Profound Medical's (PROF) CEO Arun Menawat on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/12/2021·↓ negative

Profound Medical Announces First Quarter 2021 Financial Results

GlobeNewsWire·5/12/2021·↑ positive

Profound Medical to Release First Quarter 2021 Financial Results on May 12 – Conference Call to Follow

GlobeNewsWire·4/21/2021·↑ positive

Profound Medical to Participate in the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference

GlobeNewsWire·4/14/2021·↑ positive

Profound Medical Announces the Appointment of Cynthia Lavoie to its Board of Directors

GlobeNewsWire·3/3/2021·↑ positive

Profound Medical Corp. (PROF) CEO Arun Menawat on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·3/2/2021·↓ negative